US 11,260,061 K1 (4,372nd)
	Corticosteroid containing orally disintegrating tablet compositions for eosinophilic esophagitis
Michael A. Gosselin; Jin-Wang Lai; and Gopi M. Venkatesh
Assigned to ELLODI PHARMACEUTICALS, L.P.
Trial No. IPR2025-00056, Oct. 24, 2024
Inter Partes Review Certificate for Patent 11,260,061, issued Mar. 1, 2022, Appl. No. 17/211,119, Mar. 24, 2021
Inter Partes Review Certificate issued Apr. 30, 2026